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Vortioxetine treatmentemergent mania in the elderly: a case report Dear Sir, Rates of antidepressant-induced hypomania/mania (AIHM) in unipolar depression range from 3.72% to 16.90% and occur with all antidepressants. 1 Vortioxetine is a new-generation, multimodal antidepressant, with a pro-cognitive effect in elderly depressed patients. Available meta-analyses showed no risk of vortioxetine-related AIHM, but four cases are reported in bipolar disorder (BD) and recurrent major depressive disorder (MDD). [2] [3] [4] [5] We describe a case of an AIHM induced by vortioxetine in an 82-year-old male patient with recurrent MDD. He suffered from chronic atrial fibrillation, arterial hypertension and prostate benign hyperplasia. He presented with a major depressive episode (the third in his life), with onset of MDD at the age of 28, with no psychiatric co-morbid disorders. He had no personal history of hypomanic/manic episodes or prior AIHMs, or family history of psychiatric disorders. During the current episode, sertraline was discontinued due to inefficacy, and vortioxetine was titrated up to 10 mg/ day in one week. Vortioxetine was chosen because of its established efficacy in elderly subjects with prominent cognitive symptoms and patients not fully responsive to prior treatment with selective serotonin reuptake inhibitors.
After one additional week, he developed severe manic symptoms and was admitted to the inpatient unit with a Young Mania Rating Scale score of 35. His haemogram, thyroid, kidney and liver function tests and electrolytes were within normal limits. There was no record of cognitive impairment (mini mental state examination score 28/30). A computed tomography scan of the brain was performed, showing some malacic areas due to chronic vascular disease, in the absence of cognitive decline. Vortioxetine-induced mania was diagnosed. Vortioxetine was immediately discontinued, and olanzapine 10 mg/day started. A few days later, the addition of valproate 600 mg/day was required, with resolution of the manic episode. This is the first description of a geriatric patient who developed AIHM with vortioxetine. Three more cases are reported: a 26-year-old woman with BD (with prior AIHM with sertraline) who was receiving lithium and lamotrigine 4 ; a 41-year-old male with recurrent MDD and a family history of puerperal psychosis 5 ; and a 58-yearold female with recurrent MDD with no prior history of AIHM or family history of psychiatric disorders. 2 One additional mention is made of a hypomanic episode (1/3018 patients) associated with vortioxetine in a pooled analysis of data from 11 randomized controlled trials in MDD.
This report aims to draw the attention of clinicians to the risk of AIHM in elderly patients who may be given vortioxetine mainly for its effects on cognitive functions. Interestingly, our patient presented almost none of the risk factors that have been associated with higher rates of AIHM.
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